Drug
Rbp 6300
Rbp 6300: highest development phase Phase 2, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| RBP-6300 NCT01582347 | Phase 2 | Opioid Related Disorder |
Latest
No recent events.
Follow Rbp 6300 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.